drugset
drugset / Trial / NCT05479123

Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas

NCT05479123 ↗

Phase 4 Terminated 52 enrolled The University of Texas Health Science Center, Houston
RandomizedParallel-groupOpen-labelSupportive care

Summary

The purpose of this study is to assess the baseline sleep pattern disruption for patients starting oral propranolol at the standard BID dosing regimen compared to the control (timolol) group and to determine if there is a significant improvement in the sleep patterns in infants taking oral propranolol on the TID dosing regimen versus the control (timolol) group

Timeline

Start
2022-06-23
Primary completion
2025-03-31
Completion
2025-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule 2 mg/kg Oral
Comparator Timolol Other / unclassified 0.5 % Topical

Indications

hemangioma